StockWatch
·
CAPACITE · Q2 FY27 · THE VERDICT

Record revenue, profit decline: Capacite's margin squeeze persists

Highest-ever revenue of ₹771 Cr masks a troubling divergence—net profit fell 6.8% year-on-year despite 19.3% growth at the top line. Management maintained guidance but acknowledged commodity headwinds remain unresolved, flagging a Q4 revisit as likely.

Q2 FY27 resultsCAPACITECapacite Infraprojects Ltd07 Nov 2026 · 6 min read
Revenue

₹771 Cr

+19.3% YoY; highest ever

PAT

₹47.6 Cr

-6.8% YoY; ₹51 Cr prior year

EBITDA margin

15.5%

Mid-guidance band; compressed from prior year

Order book

₹13,013 Cr

4+ quarters visibility at current run-rate

The quarter presents a textbook study in divergence. Revenue hit an all-time high of ₹771 crore, up 19.3% year-on-year, yet net profit fell 6.8% to ₹47.6 crore. The company maintained full-year guidance on all three fronts—revenue ₹4,500 crore, EBITDA margin 15.5–16.5%, cash PAT 10.5–11.25%—but the print reveals operational leverage is missing. Commodity inflation—aluminum formwork up 40%, steel up 30% versus pre-war levels—is only partially offset by contractual escalation clauses, leaving a margin squeeze that management flagged as likely to revisit in Q4 if prices do not stabilize.

Where the profit went

The H1 picture is even starker. Half-year PAT stands at ₹87 crore versus ₹98 crore in H1 FY26—down 11%—despite H1 revenue rising 13%. The gap traces to three forces. First, commodity escalation: the pass-through gap narrowed from 35% in Q1 to 2% in Q2, but absolute prices (aluminum at ₹14,500 per sqm versus ₹10,500 pre-war) remain materially elevated. Second, milestone billing delays on CIDCO (board clearance pending for profit recognition). Third, prior-year non-core gains—bad debt recovery and asset sales—that inflated H1 FY26 PAT and do not recur this year. Management confirmed it has ₹48 crore in assets marked for sale in FY27, but timing is fluid. Organic profit is roughly flat year-on-year, which is why the reported PAT decline looks worse than the operational reality.

Management's claims on the call, graded against reported results

Highest-ever quarterly revenue of ₹771 Cr; 19% YoY growth

Supported

Delivered ₹770.9 Cr, YoY +19.3%. Order book ₹13 Cr at Sept 30 supports trajectory.

EBITDA margin 15.5% Q2; PAT margin 6.1%; both on track

Overstated

Delivered OPM 15.4%, NPM 6.1%. Margin at low end of 15.5–16.5% guidance band; cash PAT ~₹83 Cr (10.7%) in-band, but reported PAT down 6.8% YoY.

Order inflow ₹2,487 Cr YTD; FY28 target ₹4,000 Cr achievable

Supported

Order book ₹13,013 Cr as of Sept 30; bid pipeline ₹3,270 Cr. FY27 run rate ~₹2,800 Cr annualized.

Commodity cost escalation mitigated by contractual pass-through; 100% private sector has pass-through

Partial

Gap narrowed Q1→Q2 (35%→2%). But aluminum at ₹14,500/sqm vs ₹10,500 pre-war remains material. Government contracts use WPI escalation; recovery lag persists.

Strong execution; working capital cycle reduced 11 days QoQ

Supported

Contract assets ₹2,279 Cr (18–20% of prior 12M revenue). Debtors ₹1,300 Cr at 120 days. WC days fell 11 days Q2 vs Q1; trend positive but absolute cycle still elevated.

What changed on this call

Key developments that move the needle
  • New large client: Mahindra Lifespace added to portfolio—mixed residential—signals market confidence in execution capability.

  • NGT suspension risk quantified: 15–20 days expected Nov 5–20 embargo. Signature Global run-rate ₹15 Cr/month implies ₹7–10 Cr Q3 revenue miss if extended.

  • Order book quality upgraded: 54% public (₹7 Cr), 46% private (₹6 Cr). Private sector skew higher-margin vs prior mix; recent wins (Mahindra Lifespace, Raymonds) reinforce.

  • Working capital trajectory confirmed: 11-day QoQ reduction to 130–135 days. Debtors ECL provisions normalized post-Q1.

  • Margin guidance caveated for Q4 revisit: Management held firm on 15.5–16.5% EBITDA but acknowledged revisit likely if commodity prices do not stabilize.

How the street is positioned

The stock trades at ₹179.94 (as of 2026-11-06), down 61.3% from its all-time high of ₹465 but up 24.35% from its 52-week low of ₹144.70. It sits above its 20-day moving average (₹162.19) but materially below both the 50-day (₹182.97) and 200-day (₹218.44) averages—a bearish technical posture. RSI 59.2 is neutral; volume is increasing. FII ownership has declined 0.8 percentage points to 14.16% quarter-on-quarter, while DII remain stable at 7.72% and the promoter holds steady at 31.69%. The 61% drawdown from the all-time high reflects market frustration with profit growth lagging revenue growth, but the 24% bounce from the lows suggests some bottom-fishing on the order book visibility thesis. The test is whether Q3–Q4 can deliver profit growth that justifies the order book.

The bull-bear ledger
  • Order book ₹13 Cr (4+ quarters visible); bid pipeline ₹3,270 Cr supports FY28 ₹4,000+ Cr target

  • Revenue guidance ₹4,500 Cr FY27 on track (₹2,500+ Cr in 9M delivered)

  • Working capital improving: 11-day QoQ reduction; debtors normalized post-Q1 provisions

  • New clients (Mahindra Lifespace) + order book mix skew 46% private (higher-margin)

  • Reported PAT down 6.8% YoY despite 19% revenue growth—margin compression clear

  • Commodity escalation gap narrowed to 2% but prices still ₹4,000/sqm above pre-war

  • Margin guidance caveated for Q4 revisit; management flagging downside scenario

  • NGT suspension recurring risk (Signature Global ₹15 Cr/month; 15–20 day ban expected Nov 5–20)

  • FII ownership declining (-0.8pp); stock down 61% from ATH, up only 24% from 52w low

Risks ranked by severity for a holder

Commodity inflation unresolved

High

Aluminum +40%, steel +30% vs pre-war. Gap narrowed to 2% but prices still elevated. If government WPI does not track market inflation, margin miss on fixed-price government contracts (54% of book). Q4 revisit flagged by management signals low conviction on margin recovery.

NGT suspension recurring

High

Signature Global suspended ~15 days Q2; 20-day ban expected Nov 5–20. Run rate ₹15 Cr/month; each ban costs ₹7–10 Cr revenue. Risk recurs in Q4 during election period. Uncontrollable per management.

Working capital intensity remains high

Medium

Contract assets ₹2,279 Cr (~18–20% of trailing 12M revenue). Debtors ₹1,300 Cr at 120 days. Milestone billing delays on CIDCO (board clearance pending) could compress H2 collections and defer profit realization.

Order execution delays

Medium

CIDCO profit pending board approval (pushed out past Q2). IIT Bombay only 13% of order (₹70 Cr of ₹550 Cr) handed over; land delays. If execution lags, Q3–Q4 revenue targets at risk.

Labor availability during elections

Medium

UP elections Q4 FY27. Management factored ₹45–50 Cr revenue loss, but if lockdown extends or election cycle lengthens, impact could exceed estimate. All projects across India exposed.

Margin guidance revision

Low

If Q3 commodity prices remain elevated or NGT suspensions extend, management will likely cut 15.5–16.5% EBITDA target in Q4. Early signal to watch; reversal would erode credibility for FY28 guidance.

What to watch next quarter
  • 1 · Commodity price stabilization (aluminum, steel)

    Q3 pricing will determine whether the 2% escalation gap holds or widens. If prices stay elevated (aluminum >₹14,000/sqm), margin recovery stalls and Q4 guidance cut is likely. This is the single biggest variable for Q3 earnings.

  • 2 · Signature Global NGT recovery post-ban

    20-day suspension expected Nov 5–20. Once relief granted, run rate should return to ₹15 Cr/month (or accelerate post-ban if backlog builds). Execution discipline on pent-up demand validates management's operating plan.

  • 3 · CIDCO milestone clearance & H2 ramp

    Board meeting cleared profitability in Q2; full profit recognition now pending formal approval. H2 targeting 35–40% run-rate increase to ₹600 Cr FY27 (from ₹177 Cr H1 = ₹30 Cr/month current). Confirmation is critical for margin recovery (higher-margin project).

  • 4 · MHADA revenue progression

    25 towers handed; targeting ₹4,200–4,300 crore over project life. Q3–Q4 should show clear ramp. Sectors 8–9 filing underway. Speed of handover and milestone releases signal project momentum.

  • 5 · FY28 order inflow & bid pipeline wins

    Bid pipeline ₹3,270 Cr; company targeting ₹1,000 Cr inflow for FY28 (vs ₹2,487 Cr YTD FY27). Q3–Q4 wins will validate ₹4,000+ crore FY28 revenue guidance. Watch for any new large clients beyond Mahindra Lifespace.

Capacite's Q2 is a paradox: the highest revenue ever, paired with declining profit year-on-year. The company is executing well on order growth (₹13 crore book, ₹3,270 Cr bid pipeline), working capital (11-day QoQ improvement), and client diversification (Mahindra Lifespace entry). But the 19% revenue growth met with 6.8% profit decline is a red flag on operational leverage and a signal that commodity inflation is outpacing contractual escalation clauses, at least for now.

Management maintained full-year guidance on all three fronts—revenue ₹4,500 crore, EBITDA margin 15.5–16.5%, cash PAT 10.5–11.25%—but flagged Q4 as a revisit point. That transparency is credible, but it also signals the company itself is uncertain on margin recovery until commodity prices stabilize. The stock's 61% drawdown from the all-time high is likely overcooked given the order visibility, but accumulation should wait for proof. The debate turns on whether Q3–Q4 can deliver **reported PAT growth**. If profit stays flat or negative YoY despite continued revenue growth, the squeeze is structural and guidance is at risk. If it turns positive—even modestly—the commodity gap is closing and the bull case validates.

The verdict: **Hold.** Strong long-term order visibility and execution track record merit a patient stance, but the margin squeeze is real and unresolved. The single number to track from here is reported PAT growth in Q3 and Q4. Until that inflects positive, this is a waiting game, not a buy.

Informational and educational content only. Not investment advice.